Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Europe region is the largest supplier of Veno-Arterial ECMO System, with a production market share nearly 42% in 2016. North America is the second largest supplier of Veno-Arterial ECMO System, enjoying production market share nearly 36% in 2016.
North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic, Maquet, Sorin, Terumo and Xenios are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Veno-Arterial ECMO System market will register a xx% CAGR in terms of revenue, the global market size will reach USD 250 million by 2024, from USD 250 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Veno-Arterial ECMO System business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Veno-Arterial ECMO System market by product type, application, key manufacturers and key regions and countries.
This study considers the Veno-Arterial ECMO System value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Portable Type
Fixed Type
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Neonatal
Pediatric
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Maquet Holding
Sorin Group
Terumo
Xenios AG
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Veno-Arterial ECMO System consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Veno-Arterial ECMO System market by identifying its various subsegments.
Focuses on the key global Veno-Arterial ECMO System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Veno-Arterial ECMO System with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Veno-Arterial ECMO System submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
